1. Home
  2. CINGW vs EVGOW Comparison

CINGW vs EVGOW Comparison

Compare CINGW & EVGOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • EVGOW
  • Stock Information
  • Founded
  • CINGW N/A
  • EVGOW 2010
  • Country
  • CINGW United States
  • EVGOW United States
  • Employees
  • CINGW 13
  • EVGOW N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • EVGOW Other Specialty Stores
  • Sector
  • CINGW Health Care
  • EVGOW Consumer Discretionary
  • Exchange
  • CINGW Nasdaq
  • EVGOW Nasdaq
  • Market Cap
  • CINGW N/A
  • EVGOW N/A
  • IPO Year
  • CINGW 2021
  • EVGOW N/A
  • Fundamental
  • Price
  • CINGW $0.04
  • EVGOW $0.33
  • Analyst Decision
  • CINGW
  • EVGOW
  • Analyst Count
  • CINGW 0
  • EVGOW 0
  • Target Price
  • CINGW N/A
  • EVGOW N/A
  • AVG Volume (30 Days)
  • CINGW N/A
  • EVGOW 74.7K
  • Earning Date
  • CINGW N/A
  • EVGOW 03-07-2025
  • Dividend Yield
  • CINGW N/A
  • EVGOW N/A
  • EPS Growth
  • CINGW N/A
  • EVGOW N/A
  • EPS
  • CINGW N/A
  • EVGOW N/A
  • Revenue
  • CINGW N/A
  • EVGOW $239,306,000.00
  • Revenue This Year
  • CINGW N/A
  • EVGOW N/A
  • Revenue Next Year
  • CINGW N/A
  • EVGOW N/A
  • P/E Ratio
  • CINGW N/A
  • EVGOW N/A
  • Revenue Growth
  • CINGW N/A
  • EVGOW 73.08
  • 52 Week Low
  • CINGW N/A
  • EVGOW $0.12
  • 52 Week High
  • CINGW N/A
  • EVGOW $1.99
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • EVGOW 43.00
  • Support Level
  • CINGW N/A
  • EVGOW $0.22
  • Resistance Level
  • CINGW N/A
  • EVGOW $0.41
  • Average True Range (ATR)
  • CINGW 0.00
  • EVGOW 0.04
  • MACD
  • CINGW 0.00
  • EVGOW 0.02
  • Stochastic Oscillator
  • CINGW 0.00
  • EVGOW 56.54

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About EVGOW EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the us. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the us. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

Share on Social Networks: